SpectraBase Spectrum ID |
GYHO3LIc4zQ |
Name |
Dormovit ME |
Classification |
Pharmaceutical drug derivative |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
264.111006999 u |
Formula |
C13H16N2O4 |
InChI |
InChI=1S/C13H16N2O4/c1-8(2)13(7-9-5-4-6-19-9)10(16)14-12(18)15(3)11(13)17/h4-6,8H,7H2,1-3H3,(H,14,16,18) |
InChIKey |
KNJBIZHKZVZBQT-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
264.281 g/mol |
Nominal Mass |
264 u |
Quality |
981 |
Retention Index |
2099 |
SMILES |
C1(C(NC(N(C1=O)C)=O)=O)(CC=1OC=CC1)C(C)C |
SPLASH |
splash10-00e9-9130000000-f2ee2e3c252cb53f0e5a |
Sample Comments |
Structure uncertain |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
5-(furan-2-ylmethyl)-1-methyl-5-(propan-2-yl)-1,3-diazinane-2,4,6-trione |
Technique |
GC/MS |
Wiley ID |
DD2024_001244 |